Biofrontera (BFRI) Retained Earnings (2020 - 2025)
Biofrontera's (BFRI) quarterly Retained Earnings came in at $138.4 million in Q4 2025, up 217.89% year-on-year from $43.5 million in Q4 2024, and up 5.67% quarter-over-quarter from $131.0 million in Q3 2025.
Biofrontera (BFRI) Retained Earnings (2020 - 2025) Analysis & Trends
Biofrontera's Retained Earnings history runs 6 years deep, the most recent figure standing at $138.4 million for Q4 2025.
- On a quarterly basis, Retained Earnings rose 217.89% year-over-year to $138.4 million in Q4 2025; TTM through Dec 2025 was $138.4 million, a 217.89% increase from a year earlier, with the FY2025 full-year figure at $138.4 million, up 217.89% from the prior year.
- Retained Earnings advanced to $138.4 million in Q4 2025 per BFRI's latest filing, from $131.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $138.4 million in Q4 2025 and bottomed at -$126.9 million in Q2 2025.
- The 5-year median for Retained Earnings is -$64.4 million (2021), against an average of $976764.7.
- Across the five-year window, Retained Earnings soared 319.11% in 2021 and slumped 212.42% in 2024, its largest moves.
- Year by year, Retained Earnings stood at $90.2 million in 2021, then sank by 188.16% to -$79.5 million in 2022, then surged by 231.34% to $104.4 million in 2023, then slumped by 212.42% to -$117.4 million in 2024, then surged by 217.89% to $138.4 million in 2025.
- Per Business Quant, the three latest BFRI Retained Earnings figures stand at $138.4 million (Q4 2025), $131.0 million (Q3 2025), and -$126.9 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Biofrontera | 12.70 Mn | 6.29 Mn | 14.09 Mn | 138.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138.41 Mn |
| Sep 30, 2025 | 130.99 Mn |
| Jun 30, 2025 | -126.90 Mn |
| Mar 31, 2025 | 122.07 Mn |
| Dec 31, 2024 | -117.41 Mn |
| Sep 30, 2024 | -116.01 Mn |
| Jun 30, 2024 | -110.30 Mn |
| Mar 31, 2024 | 104.67 Mn |
| Dec 31, 2023 | 104.44 Mn |
| Sep 30, 2023 | -103.18 Mn |
| Mar 31, 2023 | 103.72 Mn |
| Dec 31, 2022 | -79.52 Mn |
| Sep 30, 2022 | -76.70 Mn |
| Jun 30, 2022 | -74.20 Mn |
| Mar 31, 2022 | 90.72 Mn |
| Dec 31, 2021 | 90.20 Mn |
| Sep 30, 2021 | -64.40 Mn |
| Dec 31, 2020 | -41.17 Mn |